Drug intelligence / Profile preview

Beiqi Yifei

Development stage
Unknown
Lead developer
Tonghua Yongcang Pharmaceutical
Administration
Oral
01

Overview

Beiqi Yifei is a Traditional Chinese Medicine (TCM) formulation, commonly produced as capsules (Beiqi Yifei Jiaonang), developed and manufactured by Tonghua Yongcang Pharmaceutical. It is indicated for the treatment of lung-qi deficiency and is frequently used as an adjuvant therapy for patients with tuberculosis to enhance immune function and alleviate symptoms such as chronic cough and shortness of breath. The formulation is composed of several herbal and animal-derived ingredients, including *Astragalus membranaceus* (Beiqi), *Codonopsis pilosula*, *Ophiopogon japonicus*, *Schisandra chinensis*, *Fritillaria thunbergii*, and *Gekko gecko*. These components work synergistically to tonify the lung and spleen, nourish yin, and provide antitussive and expectorant effects. In the context of tuberculosis, it is used to support the patient's constitution during long-term antitubercular drug regimens.

Brand names
Beiqi Yifei
Other names
Beiqi Yifei Jiaonang北芪益肺胶囊

Beyond the preview

Go deeper on Beiqi Yifei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beiqi Yifei.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call